Table 1.
Variable | MAGGIC (13 Variables) | SHFM (20 Variables) |
---|---|---|
Age | X | X |
Male sex | X | X |
Diabetes mellitus | X | |
COPD | X | |
Current smoker | X | |
Ischemic cause | X | |
HF duration <18 mo | X | |
NYHA class | X | X |
β‐Blocker use | X | X |
ACE‐inhibitor/ARB use | X | X |
Aldosterone blocker use | X | |
Allopurinol use | X | |
Statin use | X | |
Loop diuretic dose | X | |
Systolic blood pressure | X | X |
Body mass index | X | X |
Serum creatinine | X | |
Sodium | X | |
Hemoglobin | X | |
Total cholesterol | X | |
Lymphocytes | X | |
Uric acid | X | |
Ejection fraction | X | X |
Device therapy | X | |
QRS duration | X |
ACE indicates angiotensin‐converting enzyme; ARB, angiotensin receptor blocker; COPD, chronic obstructive pulmonary disease; device therapy, intracardiac defibrillator and/or cardiac resynchronization therapy; HF, heart failure; MAGGIC, Meta‐Analysis Global Group in Chronic Heart Failure; NYHA, New York Heart Association; SHFM, Seattle Heart Failure Model.